Cell Cytometry Market Report 2025

This cell cytometry market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The cell cytometry market size has grown rapidly in recent years. It will grow from $1.41 billion in 2024 to $1.57 billion in 2025 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to the rising prevalence of chronic diseases and cancer, expansion of clinical applications, increasing use in immunophenotyping, technological integration with artificial intelligence, and development of novel fluorescent dyes and reagents.

The cell cytometry market size is expected to see rapid growth in the next few years. It will grow to $2.37 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to the integration of multi-omics approaches, increasing use in immunotherapy and cancer research, growing adoption of automated and high-throughput systems, rising investment in biotechnology and life sciences research, and growing focus on precision medicine. Major trends in the forecast period include sustainability and eco-friendly practices, miniaturization and portability of devices, expansion into non-traditional applications, growth of single-cell analysis techniques, and integration of artificial intelligence and machine learning.

The increasing demand for personalized medicine is expected to drive the growth of the cell cytometry treatment market in the future. Personalized medicine involves tailoring treatment and prevention strategies to the unique characteristics, genetics, and lifestyle of each patient, aiming for more precise and effective healthcare. This approach is gaining traction due to its potential for delivering more targeted treatments with fewer side effects, thereby improving patient outcomes. Cell cytometry plays a crucial role in personalized medicine by analyzing individual patients' cells, which facilitates the precise identification of disease markers, monitoring of immune responses, and customization of treatments based on specific cellular characteristics. For example, in February 2024, the Personalized Medicine Coalition (PMC) reported that the U.S. Food and Drug Administration approved 16 new personalized treatments for rare diseases in 2023, up from six approvals in 2022. This rising demand for personalized medicine is contributing to the growth of the cell cytometry market.

Leading companies in the cell cytometry market are focusing on developing advanced solutions such as spectral cell sorters to achieve unbiased results and enhance operational efficiency. A spectral cell sorter is a sophisticated flow cytometry device that sorts cells based on the full spectrum of fluorescence emissions rather than just a few specific wavelengths. For instance, in October 2023, Sony Corporation, a Japan-based electronics firm, introduced the FP7000 spectral cell sorter. This device offers advanced full-spectrum analysis and high-speed sorting capabilities, enabling the simultaneous detection of multiple fluorescent markers with improved accuracy. The FP7000 features Sony's patented spectral technology, which allows for precise cell identification through full-spectrum capture and deconvolution, enhancing multiplexing capabilities and resolution compared to traditional flow cytometers. Designed for user-friendly operation with intuitive software, the FP7000 is well-suited for complex research in areas such as immunology, cancer, and stem cell studies.

In October 2024, Bruker Corporation, a US-based company specializing in scientific instruments and analytical solutions, acquired Dynamic Biosensors GmbH for an undisclosed amount. This acquisition will allow Bruker to strengthen its biophysical portfolio while preserving the current organization, management, and innovative brand of Dynamic Biosensors in the biosensor market. Dynamic Biosensors GmbH, based in Germany, focuses on developing and manufacturing cutting-edge biophysical analysis tools.

Major companies operating in the cell cytometry market are Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Bruker Corporation, StemCell Technologies Canada Inc., FOSS Analytical Solutions, PerkinElmer Inc., Molecular Devices LLC, Luminex Corporation, R&D Systems, Cytek Biosciences Inc., Cell Signaling Technology Inc., Sony Biotechnology Inc., Sysmex Partec GmbH, Nexcelom Bioscience, Vajra Biometrix Private Limited, Accellix, Amphasys.

North America was the largest region in the cell cytometry market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell cytometry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell cytometry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Cell cytometry is a technique used to measure and analyze the physical and chemical properties of cells or particles in a fluid suspension. This process involves passing cells through a laser or electrical field to detect characteristics such as size, shape, granularity, and the presence of specific proteins or molecules. It is widely applied in biology, medicine, and research for immune profiling, cancer diagnostics, and assessing cellular responses to treatments.

The primary product types in cell cytometry include instruments, kits and reagents, and software and services. Instruments are tools or devices designed for scientific, medical, or technical purposes, specifically to measure, analyze, or manipulate biological, physical, or chemical properties. The technologies used include cell-based flow cytometry and beads-based flow cytometry, with applications spanning oncology, drug discovery, stem cell therapy, organ transplantation, hematology, and more. It is employed by various end-users, such as hospitals and clinics, academic and research institutions, pharmaceutical and biotechnology companies, and others.

The cell cytometry market research report is one of a series of new reports that provides cell cytometry market statistics, including cell cytometry industry global market size, regional shares, competitors with a cell cytometry market share, detailed cell cytometry market segments, market trends and opportunities, and any further data you may need to thrive in the cell cytometry industry. This cell cytometry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell cytometry market consists of revenues earned by entities by providing services such as flow cytometry analysis, cell sorting, immunophenotyping, cell viability and proliferation testing, apoptosis and cell cycle analysis, and multiplexed assays. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell cytometry market also includes sales of flow cytometers, cell sorting systems, data analysis software, consumables and accessories, imaging cytometers, laser systems, and microfluidic chips, which are used for analyzing, sorting, and characterizing cells. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.